Therapeutic Delivery

Souvie Biodelivery is focused on developing engineered exosomes for tissue and site specific active pharmaceutical ingredient (API) delivery.  Our solution has the potential to  increase biocompatibility, non-immunogenicity, and API protection to eliminate API degradation, while also increasing specificity and efficacy to virtually eliminate adverse drug reactions.